Industry reports
Editor highlights

Publication dates

All regions

Insulin Research Reports, April 2014

You might be interested in: medical equipment, drug, therapeutics, more »


 

1-20 of about 400 reports for Insulin
Insulin Infusion Pumps To Be Used with Invasive Glucose Sensor - Medical Device Safety and Approval Report - Comprehensive

Insulin Infusion Pumps To Be Used with Invasive Glucose Sensor - Medical Device Safety and Approval Report - Comprehensive

  • $ 199
  • Industry report
  • April 2014
  • by DeviceMatters

... insulin infusion pumps to be used with invasive glucose sensor - medical device safety and approval report - comprehensive the comprehensive devicematters medical device safety and approval report ...

Insulin Delivery Devices Market to 2019 - Simplified Pump Solutions and Low Cost Pens Represent Distinct Regional Growth Drivers

Insulin Delivery Devices Market to 2019 - Simplified Pump Solutions and Low Cost Pens Represent Distinct Regional Growth Drivers

  • $ 3 500
  • Industry report
  • April 2014
  • by GBI Research

... And low cost pens represent distinct regional growth driverssummarygbi research's report, 'insulin delivery devices market to 2019 - simplified pump solutions and low cost pens ...

2014 Deep Research Report on Global and China Insulin Industry

2014 Deep Research Report on Global and China Insulin Industry

  • $ 2 200
  • Industry report
  • April 2014
  • by QY Research Group

... Process, product cost structure etc. Then statistics global and china key manufactus insulin capacity production cost price gross production value gross margin etc details information, at the same time ...

Global Insulin Market Outlook 2018

Global Insulin Market Outlook 2018

  • $ 1 200
  • Industry report
  • April 2014
  • by RNCOS

... At such a high pace significantly increases the demand for insulin products. The discovery of insulin therapy has remained as a standard treatment for both type i diabetes. Owing to the growing prevalence ...

Infusion Pumps & Accessories Market by Product (Volumetric, Syringe, Enteral, Insulin, Implantable, PCA Pump), Application (Diabetes, Chemotherapy, Nutrition, Pain Management) & by End-user (Hospital, Home Healthcare) - Global Forecasts to 2018

Infusion Pumps & Accessories Market by Product (Volumetric, Syringe, Enteral, Insulin, Implantable, PCA Pump), Application (Diabetes, Chemotherapy, Nutrition, Pain Management) & by End-user (Hospital, Home Healthcare) - Global Forecasts to 2018

  • $ 4 650
  • Industry report
  • April 2014
  • by MarketsandMarkets

... In demand from hospitals to home care settings is witnessed for insulin pumps, patient-controlled analgesia pumps, and ambulatory pumps due to the increased acceptance by patients and focus for the reduction ...

Diabetes : Herbal molecules vs. Pharmaceutical drugs - Volume 1 : Cinnamon global markets, competitors and opportunities - 2014-2019 Analysis and forecasts

Diabetes : Herbal molecules vs. Pharmaceutical drugs - Volume 1 : Cinnamon global markets, competitors and opportunities - 2014-2019 Analysis and forecasts

  • $ 3 900
  • Industry report
  • March 2014
  • by Amadee+Company

... Abstractdiabetes is a metabolic disorder arising mainly due to the fault in the production of insulin or mounting resistance to its action. In the case of diabetes, the most serious problem is the side effect, which occurs due ...

Insulin Glargine   - Key patent, SPC, and data exclusivity expiry (7 country coverage)

Insulin Glargine - Key patent, SPC, and data exclusivity expiry (7 country coverage)

  • $ 460
  • Industry report
  • March 2014
  • by GenericsWeb

... insulin glargine - key patent, spc, and data exclusivity expiry (7 country coverage) pipeline selector helps you avoid hours of painstaking reserach by quickly providing you with an accurate ...

Insulin Aspart - Key patent, SPC, and data exclusivity expiry (7 country coverage)

Insulin Aspart - Key patent, SPC, and data exclusivity expiry (7 country coverage)

  • $ 460
  • Industry report
  • March 2014
  • by GenericsWeb

... insulin aspart - key patent, spc, and data exclusivity expiry (7 country coverage) pipeline selector helps you avoid hours of painstaking reserach by quickly providing you with an accurate ...

Insulin Detemir  - Key patent, SPC, and data exclusivity expiry (44 country coverage)

Insulin Detemir - Key patent, SPC, and data exclusivity expiry (44 country coverage)

  • $ 1 105
  • Industry report
  • March 2014
  • by GenericsWeb

... insulin detemir - key patent, spc, and data exclusivity expiry (44 country coverage) pipeline selector helps you avoid hours of painstaking reserach by quickly providing you with an accurate ...

Insulin Aspart - Key patent, SPC, and data exclusivity expiry (44 country coverage)

Insulin Aspart - Key patent, SPC, and data exclusivity expiry (44 country coverage)

  • $ 1 105
  • Industry report
  • March 2014
  • by GenericsWeb

... insulin aspart - key patent, spc, and data exclusivity expiry (44 country coverage) pipeline selector helps you avoid hours of painstaking research by quickly providing you with an accurate ...


» Read our Company Profiles

14 Companies for Insulin

Eli Lilly and Co.

United States

Abbott Laboratories

United States

Medtronic Inc.

United States

Lilly and Co.

United States

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.